CDKN2A and breast cancer: Finally, MGPT also led to the identification of SFs, such as two PVs in CDH1 and one PV in CDKN2A in BC patients without a personal/family history suggestive of hereditary diffuse gastric cancer or melanoma and pancreatic carcinoma syndrome, respectively.